Suppliers / Vamsi Labs

Vamsi Labs

India 199 employees 2 duplicate records merged Updated 9 July 2026

Vamsi Labs is an API manufacturer based in India. It holds 14 active US drug master files and 12 valid CEPs across a filed portfolio of 15 molecules. Its GMP standing is certified by EMA. Its most recent recorded inspection, by US FDA, closed on 16 March 2018 as VAI.

14
active US DMFs
12
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
1 of 1 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 16 March 2018 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Solapur, India 3004644745

What they file, and where

Molecule Regulators Docs
Albuterol EDQM, US FDA 3
Fluticasone Propionate EDQM, US FDA 3
Formoterol EDQM, US FDA 3
Haloperidol EDQM, US FDA 3
Tiotropium SFDA (Saudi Arabia), US FDA 3
Ipratropium EDQM, SFDA (Saudi Arabia) 2
Loperamide US FDA 2
Triamcinolone US FDA 2
Budesonide EDQM 1
Clenbuterol EDQM 1
Show all 15 molecules on file
Fenoterol EDQM 1
Fluticasone Furoate EDQM 1
Glycopyrronium EDQM 1
Salmeterol Xinafoate EDQM 1
Tiotropium Bromide Monohydrate EDQM 1

Also appears on these molecule pages

Show 1 more molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA None 1

Questions about Vamsi Labs

Does Vamsi Labs hold a US DMF or a CEP?
Vamsi Labs holds 14 active US drug master files and 12 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Vamsi Labs FDA-registered?
One site operated by Vamsi Labs carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Vamsi Labs's last inspection go?
The most recent inspection on record closed on 16 March 2018 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 1 inspection is on file.
Where does Vamsi Labs manufacture?
1 registered site is on record, in India (Solapur). Every site is listed on this page with the register it came from.
What does Vamsi Labs make?
15 molecules are on record against Vamsi Labs, including Albuterol, Fluticasone Propionate, Formoterol and Haloperidol. Each links through to that molecule's full manufacturer list.
Which regulators recognise Vamsi Labs's GMP?
Current GMP certificates are on record from EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Vamsi Labs comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 16 March 2018.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates